lactic acid has been researched along with Hepatitis C in 6 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The combination of highly active antiretroviral therapy (HAART) plus ribavirin (RBV) in patients with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfection has been reported to cause mitochondrial toxicity (MT)." | 7.76 | Mitochondrial toxicity is associated with virological response in patients with HIV and hepatitis C virus coinfection treated with ribavirin and highly active antiretroviral therapy. ( Breitenecker, F; Gangl, A; Kosi, L; Maresch, J; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rieger, A; Wrba, F, 2010) |
| "Perinatal antiretroviral (ARV) exposure has been related to hyperlactatemia and lactic acidosis in infants born to HIV-infected mothers." | 3.78 | Hyperlactatemia and in utero exposure to antiretrovirals: is the control group the clue? ( Arranz, JA; Espiau, M; Figueras, C; Martín-Nalda, A; Martínez-Gómez, X; Melendo, S; Riudor, E; Soler-Palacín, P, 2012) |
| "The combination of highly active antiretroviral therapy (HAART) plus ribavirin (RBV) in patients with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfection has been reported to cause mitochondrial toxicity (MT)." | 3.76 | Mitochondrial toxicity is associated with virological response in patients with HIV and hepatitis C virus coinfection treated with ribavirin and highly active antiretroviral therapy. ( Breitenecker, F; Gangl, A; Kosi, L; Maresch, J; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rieger, A; Wrba, F, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Driedger, M | 1 |
| Galanakis, C | 1 |
| Doyle, MA | 1 |
| Cooper, CL | 1 |
| Jyothi, KR | 1 |
| Beloor, J | 1 |
| Jo, A | 1 |
| Nguyen, MN | 1 |
| Choi, TG | 1 |
| Kim, JH | 1 |
| Akter, S | 1 |
| Lee, SK | 1 |
| Maeng, CH | 1 |
| Baik, HH | 1 |
| Kang, I | 1 |
| Ha, J | 1 |
| Kim, SS | 1 |
| Reiberger, T | 1 |
| Kosi, L | 1 |
| Maresch, J | 1 |
| Breitenecker, F | 1 |
| Payer, BA | 1 |
| Wrba, F | 1 |
| Rieger, A | 1 |
| Gangl, A | 1 |
| Peck-Radosavljevic, M | 1 |
| Soler-Palacín, P | 1 |
| Martín-Nalda, A | 1 |
| Martínez-Gómez, X | 1 |
| Melendo, S | 1 |
| Riudor, E | 1 |
| Arranz, JA | 1 |
| Espiau, M | 1 |
| Figueras, C | 1 |
| O'Hagan, DT | 1 |
| Singh, M | 1 |
| Dong, C | 1 |
| Ugozzoli, M | 1 |
| Berger, K | 1 |
| Glazer, E | 1 |
| Selby, M | 1 |
| Wininger, M | 1 |
| Ng, P | 1 |
| Crawford, K | 1 |
| Paliard, X | 1 |
| Coates, S | 1 |
| Houghton, M | 1 |
| de Mendoza, C | 1 |
| Soriano, V | 1 |
1 review available for lactic acid and Hepatitis C
| Article | Year |
|---|---|
The role of hepatitis C virus (HCV) in mitochondrial DNA damage in HIV/HCV-coinfected individuals.
Topics: Acidosis, Lactic; Anti-HIV Agents; Antiviral Agents; DNA Damage; DNA, Mitochondrial; Hepatitis C; HI | 2005 |
5 other studies available for lactic acid and Hepatitis C
| Article | Year |
|---|---|
Direct-acting antiviral hepatitis C virus treatment perturbation of the metabolic milieu.
Topics: Antiviral Agents; Biomarkers; Blood Glucose; Drug Therapy, Combination; Energy Metabolism; Female; H | 2019 |
Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication.
Topics: Animals; Antiviral Agents; Cyclosporine; Disease Models, Animal; Hepacivirus; Hepatitis C; Lactic Ac | 2015 |
Mitochondrial toxicity is associated with virological response in patients with HIV and hepatitis C virus coinfection treated with ribavirin and highly active antiretroviral therapy.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Drug Administration Schedu | 2010 |
Hyperlactatemia and in utero exposure to antiretrovirals: is the control group the clue?
Topics: Acidosis, Lactic; Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Cohort Studi | 2012 |
Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
Topics: Adjuvants, Immunologic; Animals; Cations; Cytotoxicity Tests, Immunologic; DNA, Viral; Drug Carriers | 2004 |